BRPI0813174A2 - Composição farmacêutica que compreende a combinação de um agente inibidor da enzima hmg-coa redutase e um agente inibidor da enzima lipase gastrointestinal - Google Patents
Composição farmacêutica que compreende a combinação de um agente inibidor da enzima hmg-coa redutase e um agente inibidor da enzima lipase gastrointestinalInfo
- Publication number
- BRPI0813174A2 BRPI0813174A2 BRPI0813174-0A2A BRPI0813174A BRPI0813174A2 BR PI0813174 A2 BRPI0813174 A2 BR PI0813174A2 BR PI0813174 A BRPI0813174 A BR PI0813174A BR PI0813174 A2 BRPI0813174 A2 BR PI0813174A2
- Authority
- BR
- Brazil
- Prior art keywords
- enzyme inhibitor
- reduzase
- hmg
- coa
- combination
- Prior art date
Links
- 229940125532 enzyme inhibitor Drugs 0.000 title 2
- 239000002532 enzyme inhibitor Substances 0.000 title 2
- 102000004882 Lipase Human genes 0.000 title 1
- 108090001060 Lipase Proteins 0.000 title 1
- 239000004367 Lipase Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 235000019421 lipase Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2007007283A MX2007007283A (es) | 2007-06-15 | 2007-06-15 | Composicion farmaceutica que comprende la combinacion de un agente inhibidor de la enzima hmg-coa reductasa y un agente inhibidor de la enzima lipasa gastrointestinal. |
| PCT/MX2008/000077 WO2008153374A1 (es) | 2007-06-15 | 2008-06-16 | Composición farmacéutica que comprende la combinación de un agente inhibidor de la enzima hmg-coa reductasa y un agente inhibidor de la enzima lipasa gastrointestinal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0813174A2 true BRPI0813174A2 (pt) | 2014-12-23 |
Family
ID=40129898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813174-0A2A BRPI0813174A2 (pt) | 2007-06-15 | 2008-06-16 | Composição farmacêutica que compreende a combinação de um agente inibidor da enzima hmg-coa redutase e um agente inibidor da enzima lipase gastrointestinal |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2179732B1 (pt) |
| AR (1) | AR067038A1 (pt) |
| BR (1) | BRPI0813174A2 (pt) |
| CO (1) | CO6241106A2 (pt) |
| CY (1) | CY1115453T1 (pt) |
| EC (1) | ECSP099801A (pt) |
| ES (1) | ES2492665T3 (pt) |
| GT (1) | GT200900316A (pt) |
| MX (1) | MX2007007283A (pt) |
| PL (1) | PL2179732T3 (pt) |
| UY (1) | UY31211A1 (pt) |
| WO (1) | WO2008153374A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110314232A (zh) * | 2019-08-03 | 2019-10-11 | 黄泳华 | 由脂肪酶抑制剂与羟甲戊二酰辅酶a还原酶抑制剂构成的组合物 |
| AR133035A1 (es) * | 2023-06-21 | 2025-08-20 | Shanghai Argo Biopharmaceutical Co Ltd | Composiciones y métodos para inhibir la expresión de la 3-hidroxi-3-metilglutaril-coa reductasa (hmgcr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060148721A1 (en) * | 2003-06-06 | 2006-07-06 | Erondu Ngozi E | Combination therapy for the treatment of dyslipidemia |
| WO2006109170A2 (en) * | 2005-04-14 | 2006-10-19 | Esperion Therapeutics Inc. | Combination therapy for treatment of cardiovascular diseases and related conditions |
| MXPA06010973A (es) * | 2006-09-25 | 2009-02-18 | World Trade Imp Export Wtie Ag | Composicion farmaceutica para el tratamiento del sobrepeso y la obesidad que se acompañan la dislipidemia. |
-
2007
- 2007-06-15 MX MX2007007283A patent/MX2007007283A/es active IP Right Grant
-
2008
- 2008-06-16 BR BRPI0813174-0A2A patent/BRPI0813174A2/pt not_active Application Discontinuation
- 2008-06-16 WO PCT/MX2008/000077 patent/WO2008153374A1/es not_active Ceased
- 2008-06-16 EP EP08778967.3A patent/EP2179732B1/en not_active Not-in-force
- 2008-06-16 PL PL08778967T patent/PL2179732T3/pl unknown
- 2008-06-16 ES ES08778967.3T patent/ES2492665T3/es active Active
- 2008-06-17 AR ARP080102585A patent/AR067038A1/es unknown
- 2008-07-04 UY UY31211A patent/UY31211A1/es not_active Application Discontinuation
-
2009
- 2009-12-11 CO CO09141944A patent/CO6241106A2/es not_active Application Discontinuation
- 2009-12-14 EC EC2009009801A patent/ECSP099801A/es unknown
- 2009-12-14 GT GT200900316A patent/GT200900316A/es unknown
-
2014
- 2014-08-07 CY CY20141100617T patent/CY1115453T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2179732A4 (en) | 2010-08-25 |
| UY31211A1 (es) | 2009-01-05 |
| EP2179732B1 (en) | 2014-05-14 |
| ECSP099801A (es) | 2010-01-29 |
| GT200900316A (es) | 2011-07-25 |
| MX2007007283A (es) | 2009-02-18 |
| PL2179732T3 (pl) | 2014-10-31 |
| WO2008153374A1 (es) | 2008-12-18 |
| CO6241106A2 (es) | 2011-01-20 |
| AR067038A1 (es) | 2009-09-30 |
| ES2492665T3 (es) | 2014-09-10 |
| CY1115453T1 (el) | 2017-01-04 |
| EP2179732A1 (en) | 2010-04-28 |
| WO2008153374A8 (es) | 2010-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0815170A2 (pt) | Composição farmacêutica que compreende um inibidor de sglt 2 | |
| EP2124548A4 (en) | DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF | |
| NO345139B1 (no) | Florizinanaloger som inhibitorer av glukosekotransportør 2 og farmasøytisk sammensetning derav | |
| IL192925A0 (en) | 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them | |
| CL2007002678A1 (es) | Composicion que comprende a) un primer agente seleccionado de loratadina, bifonazol, sertralina, ritonavir y atorvastatina, entre otros; y b) un segundo agente seleccionado de amprenavir, nevirapina y rosiglitazona, entre otros; kit farmaceutico, uti | |
| EP2025337A4 (en) | TOPICAL PHARMACEUTICAL COMPOSITION | |
| PT1849470T (pt) | Fármaco anticancro contendo alfa, alfa, alfa-trifluorotimidina e inibidor da timidina-fosforilase | |
| EP2005959A4 (en) | TOPICAL PHARMACEUTICAL COMPOSITION | |
| DE602007004401D1 (de) | Primerzusammensetzung und beschichteter artikel | |
| BRPI0716147A2 (pt) | modificaÇço dinÂmica de propriedades de vÍdeo | |
| ZA200802370B (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
| GB0724187D0 (en) | Aqueous curable resein composition and aqueous coating composition | |
| EP2005958A4 (en) | TOPICAL PHARMACEUTICAL COMPOSITION | |
| BRPI0719877A2 (pt) | Elementos de engaxetamento randômicos e coluna contendo os mesmos | |
| BRPI0818073A2 (pt) | Composição de fluido de tratamento de poço e métodos de uso que incluem uma formulação de percarbonato de liberação retardada | |
| EP2180891A4 (en) | COMBINATION PREPARATION WITH HMG COA REDUCTASE INHIBITORS AND ASPIRIN AND METHOD FOR THE PRODUCTION THEREOF | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| BRPI0917982A2 (pt) | composição de alvejamento particulada que compreende enzimas | |
| DE602007002084D1 (de) | Härtbare Zusammensetzung und beschichteter Artikel | |
| BRPI0914768A2 (pt) | composições farmacêuticas que compreendem um complexo de derivados de aminociclohexano e ciclodextrina | |
| EP2036895A4 (en) | HSP90 INHIBITOR | |
| BRPI0719228A2 (pt) | Composição estabilizada de prostaglandina e | |
| DE112006003909T8 (de) | Zahnklebstoff-Haftvermittler-Zusammensetzung | |
| CL2008000454A1 (es) | Un granulo que comprende un nucleo que comprende quetiapina y un agente aglutinante y una capa de recubrimiento que comprende un agente lubricante; procedimiento de preparacion; y composicion farmaceutica. | |
| IL197273A0 (en) | Pharmaceutical and sunscreen compositions comprising caspase-14 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: PPTM INTERNATIONAL, S.A.R.L. (LU) |
|
| B25A | Requested transfer of rights approved |
Owner name: TEVA PHARMACEUTICALS HOLDINGS MEXICO S.A. DE C.V. (MX) Owner name: TEVA PHARMACEUTICALS HOLDINGS MEXICO S.A. DE C.V. |
|
| B25A | Requested transfer of rights approved |
Owner name: REPRESENTACIONES E INVESTIGACIONES MEDICAS S.A. DE |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |